Evaluating Anti-Infective Drugs in the Resistant Pathogen Setting: Can We Use External Controls?

Statistical Communications in Infectious Diseases
doi 10.1515/scid-2016-0003
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Walter de Gruyter GmbH

Related search

Repurposed Anti-Cancer Drugs: The Future for Anti-Infective Therapy?

Expert Review of Anti-Infective Therapy
VirologyInfectious DiseasesMicrobiology
2020English

Development of Novel Anti-Infective Drugs Targeting Microbial Proteins

English

How Can We Treat Recurrent Herpes Virus Infection Without the Use of Antiviral Drugs?

Acta Scientific Medical Sciences
2019English

Payment Reform, Medication Use, and Costs: Can We Afford to Leave Out Drugs?

Journal of General Internal Medicine
Internal Medicine
2019English

Invasin-Functionalized Liposome Nanocarriers Improve the Intracellular Delivery of Anti-Infective Drugs

RSC Advances
ChemistryChemical Engineering
2016English

Evaluating Rates of Potential Generic Substitution for Prescription Drugs: Can We Improve on Existing Incentive Schemes?

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

The Nuclear Hormone Receptor NHR-86 Controls Anti-Pathogen Responses in C. Elegans

PLoS Genetics
EvolutionEcologyGeneticsMolecular BiologyCancer ResearchSystematicsBehavior
2019English

The High Cost of Cancer Drugs: What Can We Do?

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Sumoylation Controls Host Anti-Bacterial Response to the Gut Invasive Pathogen Shigella Flexneri

EMBO Reports
BiochemistryGeneticsMolecular Biology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy